Pdl Biopharma Inc (PDLI)

CapEx to Revenue

0.00%

Quarterly · Period ending:

PDLI logo

PDLI CapEx to Revenue

Latest reported0.00%
PDLI Quarterly CapEx/Revenue (22.50% → 0.00%)
High-resolution chart · PNG

PDLI capex to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Pdl Biopharma Inc CapEx to Revenue — Quarterly
Period endingCapEx to Revenue
0%
2.725%
1.5513%
-4.4694%
0.7721%
-8.084%
0.1079%
0%
30.868%
5.4928%
3.7014%
0.2037%
0.8025%
0.1236%
1.3356%
0.041%
0%
0%
0%
0%
0%
0%
0%
63.1893%
0.0066%
0%
0%
219.0915%
0%
0%
0%
0.0384%
0.0012%
0.0087%
0.0103%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0.0048%
0.0527%
0.7715%
0.609%
1.2163%
1.8717%
-12.8909%
25.8729%
26.7854%
15.5284%
8.8889%
25.8834%
7.1201%
10.4455%
10.0747%
12.12%
10.6673%
38.5804%
65.6621%
110.2709%
99.5035%
120.2476%
235.7379%
249.4906%
86.7578%
77.1179%
100.6534%
129.6087%
51.7206%
36.683%
27.7168%
10.4973%
6.7855%
5.0707%
12.1685%
15.8018%
5.6692%
7.0361%
20.339%
190.4762%
15%
10.7692%
50%
101.0417%
76.2712%
33.3333%
111.1111%
15.2174%
44%
34.7826%
28%
22.5%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.